This is a non-core endpoint: only basic statistics are computed.
Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites (controls excluding all cancers)
CD2_BENIGN_LIPO_SKIN_NOS_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
183
CD2_BENIGN_LIPO_SKIN_NOS_EXALLC
Control definitions
Control exclude
C3_CANCER
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D17
Name in latin
Neoplasma benignum lipomatosum cutis sive textus subcutanei locis aliis sive non specificatis
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites
- Benign lipomatous neoplasm
- Benign lipomatous neoplasm (controls excluding all cancers)
- Benign neoplasms (controls excluding all cancers)
- Benign neoplasms
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 183 | 118 | 65 |
| Unadjusted prevalence (%) | 0.05 | 0.06 | 0.04 |
| Mean age at first event (years) | 52.89 | 51.04 | 56.26 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_LIPO_SKIN_NOS_EXALLC – Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.